BLISS GVS PHARMA BULLISHBLISS GVS PHARMA
...
Channel breakout with good volume
.
.
HOLD for medium term.
TARGET 130++
Only for education purpose...
we are not financial advisor..
8.40INR
708.59 MINR
7.47 BINR
36.52 M
About BLISS GVS PHARMA LTD.
Sector
CEO
Gagan Harsh Sharma
Headquarters
Mumbai
Website
Employees (FY)
763
Founded
1984
ISIN
INE416D01022
FIGI
BBG000BHSD46
Bliss GVS Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations. Its products include capsules; creams, gels, and ointment; dry powder for injection and oral suspension; effervescent tablets; eye and ear drops; injection; liquid preparations; lotions; lozenges; nasal solution; oral solids; parenteral; pessaries; sachets; soft gelatin capsules; suppositories; suspension; syrups; tablets; and topical preparations. The company was founded on December 11, 1984 and is headquartered in Mumbai, India.
Improving & Growth Potential to be DoubleCmp 112 Levels are Mention on chart only For Educational Purpose
BLISS GVS PHARMA BLISS GVS PHARMA
CMP 90.55
17 month consolidation breakout!
One can go for Swing trade for 3-6 months
BLISSGVS Positional BuyBLISSGVS Positional Buy
Duration Few Weeks
Targets 125, 176
SL 80
Take at your Risk
BLISSGVS: Breakout of ConsolidationNSE:BLISSGVS has broken the resistance line of the consolidation phase. The target and the stop loss of the same are given. We can expect the retest till the resistance line.
will life Bliss in pharma ?Gratify if you appreciate the practice then you can like it, share it and
If you want me to investigate any chart for you then would cherish doing that for you.
Thank you for your time and support.
Stay safe.
BlisGvs Levels...W Candle (30.12.2021)BlisGvs hold in strong support ,once it reverse for this levels we expect multi bagger in year of 2022
Buy Buy strongly with stop loss 75 & super stop loss 70 for target 200-215 base on weekly chart analysts & support
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BLISSGVS is 117.10 INR — it has increased by 1.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange BLISS GVS PHARMA LTD. stocks are traded under the ticker BLISSGVS.
BLISS GVS PHARMA LTD. is going to release the next earnings report on May 17, 2024. Keep track of upcoming events with our Earnings Calendar.
BLISSGVS stock is 3.56% volatile and has beta coefficient of 1.32. Check out the list of the most volatile stocks — is BLISS GVS PHARMA LTD. there?
Yes, you can track BLISS GVS PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
BLISSGVS stock has risen by 4.27% compared to the previous week, the month change is a 2.40% rise, over the last year BLISS GVS PHARMA LTD. has showed a 53.07% increase.
BLISSGVS net income for the last quarter is 276.10 M INR, while the quarter before that showed 423.07 M INR of net income which accounts for −34.74% change. Track more BLISS GVS PHARMA LTD. financial stats to get the full picture.
Today BLISS GVS PHARMA LTD. has the market capitalization of 11.93 B, it has increased by 3.03% over the last week.
Yes, BLISSGVS dividends are paid annually. The last dividend per share was 0.50 INR. As of today, Dividend Yield (TTM)% is 0.44%. Tracking BLISS GVS PHARMA LTD. dividends might help you take more informed decisions.
BLISS GVS PHARMA LTD. dividend yield was 0.70% in 2022, and payout ratio reached 7.32%. The year before the numbers were 0.65% and 34.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, BLISSGVS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BLISS GVS PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 763.00 employees. See our rating of the largest employees — is BLISS GVS PHARMA LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BLISS GVS PHARMA LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BLISS GVS PHARMA LTD. stock shows the buy signal. See more of BLISS GVS PHARMA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BLISS GVS PHARMA LTD. EBITDA is 1.29 B INR, and current EBITDA margin is 15.59%. See more stats in BLISS GVS PHARMA LTD. financial statements.